a note on software as a medical device samd in the u s

PDF · 24 Sept 2025

This Harvard Business School draft note (authors Satish Tadikonda, Harshita Menon, William Marks; dated August 27, 2024) explains Software as a Medical Device (SaMD) in the U.S., covering definitions, FDA/IMDRF risk-classification frameworks, market trends, development and lifecycle practices, cybersecurity and risk management, and future directions including AI/ML integration and autonomous surgery. It is written as a practical primer for firms and students navigating SaMD development and regulation.

Questions this document answers

Satish Tadikonda; Harshita Menon; William Marks.

August 27, 2024.

"software intended to be used for one or more medical purposes without being part of a hardware medical device."

President and Fellows of Harvard College, 2024.

More from Stéphane

PDF

Profile (8).pdf

1w ago
PDF

A Note on U.S. Drug Pricing.pdf

1y ago
PDF

A Note on the Journey of an Outpatient Prescription Script.pdf

1y ago
PDF

A Note on the FDA Perspective on Combination Therapeutic and Medical Devices.pdf

1y ago
PDF

A Note on Preparing a New Drug Application and a Biologics License Application.pdf

1y ago
PDF

A Note on Non-Dilutive Funding for Life Sciences Startups.pdf

1y ago
PDF

A Note on Contract Outsourcing in the Life Sciences.pdf

1y ago
PDF

A Note on Biotech Financing.pdf

1y ago
PDF

A Managerial Perspective on Clinical Trials.pdf

1y ago
PDF

Rock_Center_HC_LS_Translating IP.pdf

1y ago
PDF

Rock_Center_HC_LS_Ideation_Validation.pdf

1y ago
See all content